FI981624A - Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi - Google Patents

Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi Download PDF

Info

Publication number
FI981624A
FI981624A FI981624A FI981624A FI981624A FI 981624 A FI981624 A FI 981624A FI 981624 A FI981624 A FI 981624A FI 981624 A FI981624 A FI 981624A FI 981624 A FI981624 A FI 981624A
Authority
FI
Finland
Prior art keywords
compositions
methods
borrelia burgdorferi
burgdorferi antigens
administering
Prior art date
Application number
FI981624A
Other languages
English (en)
Swedish (sv)
Other versions
FI981624A0 (fi
Inventor
Alan G Garbour
Catherine J Luke
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK590288A external-priority patent/DK590288D0/da
Application filed by Univ Texas filed Critical Univ Texas
Publication of FI981624A0 publication Critical patent/FI981624A0/fi
Publication of FI981624A publication Critical patent/FI981624A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
FI981624A 1988-10-24 1998-07-16 Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi FI981624A (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK590288A DK590288D0 (da) 1988-10-24 1988-10-24 Kemiske forbindelser
US42288189A 1989-10-18 1989-10-18
US92479892A 1992-08-06 1992-08-06
US08/079,601 US5523089A (en) 1988-10-24 1993-06-22 Borrelia antigen
US08/588,637 US7094391B1 (en) 1988-10-24 1996-01-19 Compositions and methods for administering Borrelia burgdorferi antigens
PCT/US1997/000557 WO1997026006A1 (en) 1988-10-24 1997-01-17 Compositions and methods for administering borrelia burgdorferi antigens

Publications (2)

Publication Number Publication Date
FI981624A0 FI981624A0 (fi) 1998-07-16
FI981624A true FI981624A (fi) 1998-08-05

Family

ID=36821664

Family Applications (1)

Application Number Title Priority Date Filing Date
FI981624A FI981624A (fi) 1988-10-24 1998-07-16 Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi

Country Status (8)

Country Link
US (1) US7094391B1 (fi)
EP (1) EP0876156A4 (fi)
JP (1) JP2000507209A (fi)
AU (1) AU740048B2 (fi)
FI (1) FI981624A (fi)
NO (1) NO983220L (fi)
WO (1) WO1997026006A1 (fi)
ZA (1) ZA97459B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007318026B2 (en) * 2006-11-03 2013-04-18 Merck Sharp & Dohme (Holdings) Pty Ltd Canine Lyme disease vaccine
ATE496935T1 (de) * 2007-02-22 2011-02-15 Baxter Int Verfahren zur aufreinigung hydrophober proteine
WO2011143617A1 (en) 2010-05-14 2011-11-17 Baxter International Inc. Chimeric ospa genes, proteins, and methods of use thereof
EP2877206B1 (en) 2012-07-27 2019-11-27 Baxalta GmbH Compositions comprising chimeric ospa molecules and methods of use thereof
WO2016193370A1 (en) * 2015-06-02 2016-12-08 De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport Surface display of antigens on gram-negative outer membrane vesicles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
GB1596653A (en) * 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine
IT1223777B (it) * 1988-08-18 1990-09-29 Gevipi Ag Rubinetto a due uscite con inversore a depressione
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
CA2084413A1 (en) * 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease

Also Published As

Publication number Publication date
EP0876156A4 (en) 2004-09-08
NO983220D0 (no) 1998-07-13
FI981624A0 (fi) 1998-07-16
ZA97459B (en) 1997-08-04
NO983220L (no) 1998-09-14
AU740048B2 (en) 2001-10-25
EP0876156A1 (en) 1998-11-11
WO1997026006A1 (en) 1997-07-24
JP2000507209A (ja) 2000-06-13
AU1747097A (en) 1997-08-11
US7094391B1 (en) 2006-08-22

Similar Documents

Publication Publication Date Title
IT1232831B (it) Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono
DE10199066I1 (de) Pharmazeutische Zusammensetzung
DE3486441D1 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
BR8905204A (pt) Composicao colutoria
TR25923A (tr) Deterjan terkipleri ve bunlari hazirlamaya mahsus usul
SE8801813L (sv) Pharmaceutical composition
IT8948460A0 (it) Composizione adesiva per protesi dentarie e procedimento per la sua preparazione
LV10573A (lv) Panemiens farmaceitiska sastava iegusanai
IT9048558A0 (it) Composizione adesiva per protesi dentarie e procedimento per la sua preparazione.
BR8902338A (pt) Composicao oral
FI891145A (fi) Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi
BR8906787A (pt) Composicao
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
BR8903994A (pt) Composicao oral
BR8801758A (pt) Composicao em particulas
FI981624A (fi) Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi
BR8905444A (pt) Composicoes e aplicacao
BR8902491A (pt) Composicao
TR26099A (tr) Islah edilmis pestisid terkip
BR8907528A (pt) Composicao crio-protetora
GB8821656D0 (en) Pharmaceutical compositions for eliciting immunostimulant effect
DE69025414D1 (de) Vakzin-Zusammensetzung
DK597784D0 (da) Silanmodificerede esterblandinger, fremgangsmaader til deres fremstilling samt deres anvendelse i farmaceutiske og kosmetiske praeparater

Legal Events

Date Code Title Description
MA Patent expired